首页> 外文OA文献 >The effects of naproxen and sulindac on renal function and their interaction with hydrochlorothiazide and piretanide in man.
【2h】

The effects of naproxen and sulindac on renal function and their interaction with hydrochlorothiazide and piretanide in man.

机译:萘普生和舒林酸对人肾功能的影响及其与氢氯噻嗪和吡咯他尼的相互作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have studied the effect of a single dose challenge of naproxen (500 mg) and sulindac (200 mg) on renal function in five volunteers, and the effect of a single dose challenge of the thiazide, hydrochlorothiazide (100 mg), and loop diuretic, piretanide (6 mg) on renal function when the diuretics were given alone or when superimposed on chronic therapy of either naproxen or sulindac. None of the nonsteroidal anti-inflammatory drug (NSAID) or diuretic exposures significantly influenced glomerular filtration rate, as measured by creatinine clearance. Over the first 4 h of the study, both naproxen and sulindac reduced fractional excretion of sodium by approximately 50%. Sulindac also caused a significant uricosuria whilst naproxen promoted urate retention. Similar changes were observed over 8 h. Superimposition of either hydrochlorothiazide or piretanide on top of chronic sulindac therapy resulted in a blunting of the natriuresis by approximately 30% compared to when these diuretics were given alone: the action of the diuretics was unchanged by naproxen. Sulindac pretreatment did not alter the urinary excretion of either hydrochlorothiazide or piretanide; naproxen did not alter hydrochlorothiazide excretion. On the basis of these findings, it is concluded that NSAIDs exert direct tubular effects that do not necessarily interfere with the delivery of diuretics to their sites of action within the nephron.
机译:我们研究了萘普生(500毫克)和舒林酸(200毫克)的单剂量激发对五名志愿者的肾功能的影响,以及噻嗪,氢氯噻嗪(100毫克)和loop利尿剂的单剂量激发的影响单独使用利尿剂或与萘普生或舒林酸联合长期使用时,吡咯他尼(6 mg)可改善肾功能。以肌酐清除率衡量,非甾体类抗炎药(NSAID)或利尿剂暴露均未显着影响肾小球滤过率。在研究的前4小时内,萘普生和舒林酸都将钠的分数排泄降低了约50%。舒林酸也引起严重的尿酸尿症,而萘普生促进尿酸盐保留。在8小时内观察到类似的变化。与单独使用这些利尿剂时相比,在慢性舒林酸治疗上叠加氢氯噻嗪或吡咯他尼会导致利尿剂变钝约30%:萘普生不会改变利尿剂的作用。舒林酸预处理不改变氢氯噻嗪或吡咯他尼的尿排泄;萘普生没有改变氢氯噻嗪的排泄。基于这些发现,可以得出结论,非甾体抗炎药具有直接的肾小管作用,并不一定干扰利尿剂向肾单位内作用部位的传递。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号